CS0159 placebo

DRUG2 trials

Sponsors

Shanghai Jiao Tong University School of Medicine

Conditions

Diabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatohepatitis (MASH)Non-alcoholic Fatty Liver DiseaseObesityType 2 Diabetes

Unknown Phase

Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM

CompletedNCT06492330

Shanghai Jiao Tong University School of MedicineDiabetes Mellitus, Type 2, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Obesity

Start: 2024-07-19End: 2025-04-22Updated: 2025-06-03

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Not yet recruitingNCT07570810

Shanghai Jiao Tong University School of MedicineNon-alcoholic Fatty Liver Disease, Obesity, Type 2 Diabetes

Start: 2026-06-01End: 2026-12-31Target: 30Updated: 2026-05-06